| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| Cost of Revenue | $0 | — |
| Gross Profit | $0 | — |
| R&D Expense | $821K | +133.1% |
| SG&A Expense | $1.9M | -6.6% |
| Operating Income | -$1.9M | +6.6% |
| Interest Expense | $475K | -63.1% |
| Pre-tax Income | -$147K | +95.6% |
| Income Tax | $0 | — |
| Net Income | -$531K | +85.7% |
| EPS (Basic) | $0.00 | +100.0% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $234K | -70.5% |
| Short-term Investments | $0 | — |
| Inventory | $0 | — |
| Current Assets | $328K | -90.7% |
| Total Assets | $2.5M | -76.4% |
| Current Liabilities | $3.9M | -54.2% |
| Total Liabilities | $4.3M | -64.7% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.9M | +14.6% |
| Investing Cash Flow | $1.5M | -68.8% |
| Financing Cash Flow | -$496K | +66.4% |
| Stockholders' Equity |
| -$1.8M |
| -21.0% |